CN Patent

CN114478528A — 芳甲酰取代的三环化合物及其制法和用途

Assigned to Genfleet Therapeutics Shanghai Inc · Expires 2022-05-13 · 4y expired

What this patent protects

本发明公开了一种对BTK具有抑制作用的芳甲酰取代的三环化合物或其药学上可接受的盐、立体异构体、溶剂合物或前药，如式I所示，式中各基团的定义详见说明书。此外，本发明还公开了包含该化合物的药物组合物，及其在制备与BTK相关和/或与B细胞活化异常相关的疾病或病症的药物中的应用。

USPTO Abstract

本发明公开了一种对BTK具有抑制作用的芳甲酰取代的三环化合物或其药学上可接受的盐、立体异构体、溶剂合物或前药，如式I所示，式中各基团的定义详见说明书。此外，本发明还公开了包含该化合物的药物组合物，及其在制备与BTK相关和/或与B细胞活化异常相关的疾病或病症的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN114478528A
Jurisdiction
CN
Classification
—
Expires
2022-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Genfleet Therapeutics Shanghai Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.